Bill of the Month
麻豆女优 Health News, in collaboration with The Washington Post, examines and decodes your perplexing medical bills.
Investigations
Priced Out
America鈥檚 health insurance crisis
Deadly Denials
Prior authorization has become a confusing maze that denies or delays care, burdens physicians with paperwork, and perpetuates racial disparities.
401 - 417 of 417 Results
-
As Care Shifts From Hospital To Home, Guarding Against Infection Falls To Families
Despite a lack of medical training, relatives increasingly are assigned complex, risky medical tasks at home, such as maintaining catheters. If done incorrectly, blood clots, infections, even death can result.
-
St. Kitts Launches Probe Of Herpes Vaccine Tests On U.S. Patients
After a Kaiser Health News report on an offshore herpes vaccine trial that skirted FDA regulations, St. Kitts and Nevis officials claim they had no knowledge of the testing. An investigation is underway.
-
Offshore Human Testing Of Herpes Vaccine Stokes Debate Over U.S. Safety Rules
Prominent businessmen and an American university supported offshore testing of an experimental vaccine.
-
When Wounds Won’t Heal, Therapies Spread 鈥 To The Tune Of $5 Billion
The market for wound care products booms among a growing older and diabetic patient pool, but many treatments are untested and funding for research falls short.
-
Follow The Money: Drugmakers Deploy Political Cash As Prices And Anger Mount
Embattled opioid seller Mallinckrodt is one of many pharmaceutical companies boosting political contributions and lobbying on Capitol Hill.
-
Target Of Medicare Insider Trading Case Boasted He Was Unstoppable 鈥楤east鈥
Prosecutors say hedge-fund traders made millions trading on information leaked from Medicare.
By Christina Jewett and Melissa Bailey -
With Drug Costs In Crosshairs, Health Firms Gave Generously To Trump鈥檚 Inauguration
Led by Pfizer and Amgen, about 10 health care firms contributed to President Donald Trump鈥檚 inauguration, which earned them entry into private events with the president and vice president.
-
Treating Cancer: Hope Vs. Hype
Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
By Liz Szabo -
Grassley Launches Inquiry Into Orphan Drugs After KHN Investigation
Citing a Kaiser Health News investigation, Senate Judiciary Committee Chairman Chuck Grassley vows to examine the orphan drug program and possible fixes.
-
Repeal & Replace Watch
HHS Pick Price Made ‘Brazen’ Stock Trades While His Committee Was Under Scrutiny
With federal investigators bearing down on his committee, Rep. Tom Price, R-Ga., who is line to be secretary of the Department of Health and Human Services, showed little restraint in investing in health companies.
By Marisa Taylor and Christina Jewett -
Women Fear Drug They Used To Halt Puberty Led To Health Problems
Despite questions about Lupron鈥檚 lasting side effects and minimal study into its safety, the FDA sped approval of the drug to market. Years later, some young women are still living with the consequences.
-
The Orphan Drug Machine
Sky-High Prices For Orphan Drugs Slam American Families And Insurers
Orphan drugs for rare diseases have helped or saved hundreds of thousands of patients like 2-year-old Luke Whitbeck, but families and insurers are picking up the astronomical cost.
By Sarah Jane Tribble and Sydney Lupkin -
The Orphan Drug Machine
Drugmakers Manipulate Orphan Drug Rules To Create Prized Monopolies
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives but nearly a third of those products aren鈥檛 new or were repurposed multiple times, an investigation shows.
By Sarah Jane Tribble and Sydney Lupkin -
Repeal & Replace Watch
Top Price Contributor Allegedly Leaned On Employees To Support PAC
President-elect Donald Trump鈥檚 Cabinet pick Tom Price "assisted" a company and campaign donor who tapped executives with an urgent request to donate.
By Marisa Taylor and Christina Jewett -
Trump’s HHS Nominee Got A Sweetheart Deal From A Foreign Biotech Firm
Price and another influential GOP congressman got a discounted deal as an Australian firm seeking federal approval sought 鈥渟ophisticated U.S. investors.鈥
By Jay Hancock and Rachel Bluth -
Trump’s Health Secretary Nominee Sought Special Treatment for Industry Donors
Rep. Tom Price advocated on everything from a sperm test to a hot pepper ingredient on behalf of medical interests that included campaign donors.
By Marisa Taylor and Christina Jewett -
Victims Seek Payments As ‘Dr. Death’ Declares Innocence
While hundreds of his former patients submit claims for restitution, a Detroit cancer doctor convicted of making millions by purposefully poisoning them with drugs they didn鈥檛 need vows to prove his innocence.